Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, August 5 at 2:00 PM EDT

Register Free →

Clinical Trial Design and Efficacy Data Generation

Active
Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract calls for the design and execution of clinical trials aimed at evaluating the safety, wound closure, infection control, and functional regeneration outcomes of medical interventions in patients with burn and trauma injuries. The work requires rigorous scientific methodology to generate robust efficacy data that supports regulatory and clinical adoption, with a focus on measurable endpoints related to tissue recovery and patient outcomes. The trials must be conducted in accordance with established clinical standards and are intended to provide evidence of therapeutic effectiveness under real-world conditions. This is a subcontract under the Aspr Administration for Strategic Preparedness and Response, part of the Department of Health and Human Services, with a solicitation posted on July 28, 2026, and a response deadline of August 28, 2026. The work is classified under NAICS code 541711, indicating research and development in the life sciences. The performance location is designated with a zip code of 77416, though no specific city or state is provided, and no point of contact details are listed. The contract does not include a set-aside designation, and all eligible entities may respond, with emphasis placed on technical capability, trial design expertise, and experience in trauma and burn clinical research.

General Info

Design and execute clinical trials for burn and trauma treatments with measurable recovery outcomes under ASPR oversight.

Agency

Department Of Health And Human Services → Aspr Administration For Strategic Preparedness And ResponseView Agency

NAICS

541711 - Research and Development in BiotechnologyView NAICS

Place of Performance

77416, DC, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

Posted

subcontract

Response Deadline

Submission deadline

Response Deadline

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → Aspr Administration For Strategic Preparedness And Response
ContactsNo contacts available
OfficeN/A
Organization / Agency
Department Of Health And Human Services → Aspr Administration For Strategic Preparedness And Response
View Agency Profile
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Design and execution of clinical trials to demonstrate safety, wound closure, infection control, and functional regeneration in burn and trauma patients.

Similar Contracts

Same NAICS industry code

NAICS: 541711
Grant
Preclinical Animal Studies for Neurofibromatosis ResearchThe contract seeks to conduct preclinical in vivo studies using genetically engineered mouse models or alternative animal models of neurofibromatosis to assess the efficacy of therapeutic interventions, track tumor progression, and investigate underlying biological mechanisms. The work requires advanced expertise in animal modeling, tumor biology, and preclinical drug evaluation, with a focus on generating robust, reproducible data to support future clinical translation. All studies must be conducted in accordance with established ethical and scientific standards for animal research, with detailed documentation of methodologies, outcomes, and adverse events. This subcontract is issued under the Defense Health Agency Contracting Activity and falls under NAICS code 541711, indicating it supports research and development in the physical, engineering, and life sciences. The solicitation was posted on June 25, 2026, with a response deadline of September 22, 2026, and is open to qualified entities capable of executing complex preclinical studies. While the place of performance and point of contact details are unspecified, successful proposers must demonstrate capacity to manage animal facilities, comply with regulatory requirements, and deliver high-quality, timely results in support of neurofibromatosis research objectives under the Department of Defense.
Defense Health Agency Contracting Activity - Dhaca

POSTED

about 1 month ago

DEADLINE

in about 2 months
View Details
NAICS: 541711
Grant
Collaborative Biomedical Research ExecutionThis contract enables a collaborative biomedical research effort focused on neurofibromatosis, requiring coordinated hypothesis-driven investigations led by an Initiating Principal Investigator and a Partnering Principal Investigator. The work encompasses the design of experiments, generation of empirical data, and rigorous milestone-based progress reporting to ensure scientific rigor and accountability. The project is structured as a subcontract under the Defense Health Agency Contracting Activity, falling under the NAICS code for research and development in the physical, engineering, and life sciences, and is intended to advance understanding of neurofibromatosis through integrated scientific contributions. The solicitation was posted on June 25, 2026, with a response deadline of September 22, 2026, and is managed by the Department of Defense through its health research infrastructure. While no set-aside provisions or specific location details are provided, the emphasis is firmly on outcome-driven research with clearly defined deliverables tied to research milestones. The effort requires close alignment between the two principal investigators to ensure cohesive experimental planning, data integrity, and timely reporting, reflecting a strategic investment in translational medical science with potential implications for defense-relevant health conditions.
Defense Health Agency Contracting Activity - Dhaca

POSTED

about 1 month ago

DEADLINE

in about 2 months
View Details
NAICS: 541711
Grant
Collaborative Research Partnership (Partnering PI Option)This contract establishes a collaborative research partnership where a Partnering Principal Investigator from an external institution will co-lead the research effort alongside the primary team, sharing equal responsibility for scientific direction, project management, and deliverables. Funding is jointly allocated between the participating institutions, ensuring aligned resources and mutual accountability for outcomes, with the work focused on health-related research under the Defense Health Agency Contracting Activity. The initiative falls under NAICS code 541711, indicating it is within the scientific research and development sector, and is structured as a subcontract to support integrated, multi-institutional innovation. The opportunity was posted on June 18, 2026, with a deadline for responses set for September 28, 2026, providing potential partners a defined window to submit proposals. The partnership is expected to be conducted in alignment with the mission of the Department of Defense, addressing critical health priorities through joint scientific leadership. There is no set-aside designation specified, meaning eligibility is open to qualified institutions regardless of size or status, and no specific location is designated for performance, allowing flexibility in where the research activities are carried out as long as the objectives are met collaboratively.
Defense Health Agency Contracting Activity - Dhaca

POSTED

about 1 month ago

DEADLINE

in 2 months
View Details
NAICS: 541711
Grant
Kidney Cancer Clinical Research ExecutionThe contract titled Kidney Cancer Clinical Research Execution aims to advance clinical and translational research focused on kidney cancer through comprehensive scientific activities including study design, patient data collection, biomarker analysis, and therapeutic development. The work is intended to support the development of innovative treatments and diagnostic strategies by integrating clinical observations with laboratory research, ensuring findings are rapidly translated into improved patient outcomes. The project requires expertise in oncology research methodologies, rigorous data management, and interdisciplinary collaboration to address critical gaps in kidney cancer understanding and care. This subcontract is issued by the Defense Health Agency Contracting Activity under the Department of Defense and falls under NAICS code 541711, indicating it is related to research and development in the life sciences. The opportunity was posted on June 18, 2026, with a response deadline of September 28, 2026, providing potential applicants approximately three months to prepare and submit proposals. The place of performance and specific office address details are not specified, suggesting flexibility in location but requiring proposers to align with the overarching objectives of the Department of Defense’s medical research priorities. All work must demonstrate scientific excellence, feasibility, and direct relevance to advancing kidney cancer therapeutics within a clinical context.
Defense Health Agency Contracting Activity - Dhaca

POSTED

about 1 month ago

DEADLINE

in 2 months
View Details
NAICS: 541711
Federal
Infectious Disease Vaccine DevelopmentThe contract involves licensing the NanoFET platform to enable rapid-response vaccine development against viral and bacterial pathogens, leveraging its unique adjuvant-free immune activation and modular antigen integration capabilities. This technology allows for swift adaptation to emerging infectious threats by streamlining the design and production of vaccines without relying on traditional immune-stimulating additives, significantly reducing development timelines and enhancing safety profiles. The work is structured as a subcontract under the Department of Energy, with performance centered at Los Alamos, New Mexico, and is targeted toward advancing national defense and public health preparedness through next-generation vaccine platforms. The opportunity is open for proposals until December 18, 2026, and falls under NAICS code 541711, indicating it targets research and development in the physical, engineering, and life sciences. The contracting entity is Triad, the DOE Contractor, and the initiative aligns with broader federal efforts to build resilient, scalable biodefense capabilities. Participants must demonstrate technical proficiency in the NanoFET platform, experience in infectious disease vaccine design, and the capacity to execute rapid development cycles under strict timelines. Success in this effort will contribute directly to scalable, next-generation immunization technologies capable of addressing current and future biological threats.
Triad - DOE Contractor

POSTED

about 1 month ago

DEADLINE

in 5 months
View Details
NAICS: 541711
Federal
Modular Cancer Immunotherapy DevelopmentThe contract entails the license and development of the NanoFET platform for the creation of targeted cancer immunotherapies, leveraging its modular scaffold to deliver tumor-specific antigens and immune stimulators in a precise and effective manner. The work is focused on advancing next-generation immunotherapeutic approaches by engineering the platform to enhance immune recognition and response against cancer cells, with the goal of improving therapeutic outcomes and reducing off-target effects. The project requires collaboration to optimize the platform’s design, validate its efficacy in preclinical models, and prepare for subsequent clinical translation, all grounded in cutting-edge nanotechnology and immunological science. The contract is a subcontract under the Department of Energy, with performance centered in Los Alamos, New Mexico, 87545, and is classified under NAICS code 541711 for research and development in the physical, engineering, and life sciences. The solicitation was posted on June 17, 2026, with a response deadline of December 18, 2026, indicating a strategic timeline for proposal submission and evaluation. While details on set-aside status and point of contact are not provided, the project is positioned to align with national priorities in advanced biomedical innovation and cancer treatment, leveraging federal research infrastructure and expertise to drive transformative therapeutic solutions.
Triad - DOE Contractor

POSTED

about 1 month ago

DEADLINE

in 5 months
View Details

More opportunities from Department Of Health And Human Services → Aspr Administration For Strategic Preparedness And Response

Same awarding agency

NAICS: 484121
New
Federal
Nationwide and International Medical Logistics & DistributionThe contract enables the rapid deployment and distribution of dermal substitutes across the United States and internationally, relying on resilient supply chains that operate under ambient conditions without the need for refrigeration or specialized storage. This effort supports the strategic medical preparedness goals of the Department of Health and Human Services’ Administration for Strategic Preparedness and Response, ensuring timely access to critical wound care solutions during emergencies or large-scale health events. The logistics network must be scalable, responsive, and capable of maintaining product integrity through diverse environmental and geographic conditions. Subcontractors are expected to manage end-to-end distribution channels that are efficient, secure, and compliant with federal medical logistics standards. The opportunity is open for bidding until August 28, 2026, with performance centered on a primary location identified by the zip code 77416. The NAICS code 484121 indicates that the work falls under general freight trucking, suggesting a heavy reliance on ground transportation infrastructure, though global reach implies coordinated international shipping protocols. There is no set-aside designation, making it accessible to all qualified vendors regardless of business size or ownership structure.
General Freight Trucking, Long-Distance, Truckload

POSTED

1 day ago

DEADLINE

in about 1 month
View Details
NAICS: 541611
New
Federal
Regulatory Strategy and FDA Submission SupportThe contract seeks comprehensive support for regulatory documentation and submissions to secure FDA approval or clearance for a dermal substitute, covering all critical pathways including Investigational Device Exemption IDE, 510(k) premarket notification, and Premarket Approval PMA. The work involves developing strategic regulatory plans, preparing technical and clinical documentation, coordinating with FDA reviewers, and ensuring compliance with all applicable federal requirements throughout the submission lifecycle. The contractor will be responsible for delivering timely, accurate, and scientifically robust submissions that align with current regulatory expectations and facilitate timely decision-making by the agency. This subcontract is issued under the authority of the Assistant Secretary for Preparedness and Response, part of the Department of Health and Human Services, with a North American Industry Classification System code of 541611 for management, scientific, and technical consulting services. The opportunity was posted on July 28, 2026, and responses are due by August 28, 2026. Performance is expected to be conducted from a location with a zip code of 77416, though no specific city or state is designated. The contract does not specify any set-aside status, and no point of contact information is provided publicly, with the full details accessible via the SAM.gov link.
Administrative Management and General Management Consulting Services

POSTED

1 day ago

DEADLINE

in about 1 month
View Details
NAICS: 325411
New
Federal
Surge-Capable Domestic BiomanufacturingThe contract seeks to establish large-scale domestic manufacturing of dermal substitutes in the United States with built-in surge capacity to support mass casualty and emergency response scenarios. The effort is focused on creating a resilient, onshore production capability capable of rapidly scaling output during public health emergencies, ensuring timely availability of critical wound care products when demand spikes. This initiative is aligned with national preparedness goals and underscores a strategic push to reduce reliance on overseas supply chains for life-saving medical materials. The award is structured as a subcontract under the Administration for Strategic Preparedness and Response within the Department of Health and Human Services, with a North American Industry Classification System code of 325411 for pharmaceutical and medicine manufacturing. The solicitation was posted on July 28, 2026, and responses are due by August 28, 2026. Although the place of performance is listed with a zip code of 77416, no specific city or state is provided, and no point of contact details are included. The contract does not specify a set-aside status, indicating it is open to all qualified entities regardless of size or ownership. The focus remains on achieving domestic production capacity that can maintain steady output and immediately ramp up during crises.
Medicinal and Botanical Manufacturing

POSTED

1 day ago

DEADLINE

in about 1 month
View Details
NAICS: 325412
New
Federal
Ambient-Stable Biologic Product FormulationThe contract seeks the development of advanced stabilization techniques to enable biologic products to maintain full efficacy when stored at ambient temperatures ranging from 20 to 25 degrees Celsius, with a target shelf life of 2 to 5 years. This effort is focused on overcoming the current reliance on cold-chain logistics by creating formulation solutions that preserve structural integrity, biological activity, and safety of sensitive biologics under real-world storage conditions. The work will involve innovative approaches in excipient design, lyophilization, nano-encapsulation, or other emerging technologies that prevent degradation pathways such as aggregation, deamidation, and oxidation without the need for refrigeration. This subcontract is issued by the Agency for Strategic Preparedness and Response within the Department of Health and Human Services under NAICS code 325412, which covers pharmaceutical and biological product manufacturing. The opportunity was posted on July 28, 2026, with a response deadline of August 28, 2026. Performance is expected to take place in the area associated with ZIP code 77416, though no specific city or state is provided. The contract aims to bolster national preparedness by ensuring reliable access to life-saving biologics during emergencies, in resource-limited settings, or in regions with inconsistent infrastructure, reducing dependency on temperature-controlled distribution systems.
Pharmaceutical Preparation Manufacturing

POSTED

1 day ago

DEADLINE

in about 1 month
View Details
NAICS: 339113
New
Federal
Advanced Dermal Regeneration Substitutes for Treatment of Severe Burns and Complex Traumatic InjuriesThe Biomedical Advanced Research and Development Authority (BARDA) is seeking information on advanced dermal regeneration technologies capable of addressing large-area skin loss resulting from thermal burns or traumatic injuries in mass casualty scenarios. The solicitation, titled Advanced Dermal Regeneration Substitutes for Treatment of Severe Burns and Complex Traumatic Injuries and identified by BARDA-CBRN-07282026, aims to evaluate commercially available or near-commercial technologies that support temporizing wound healing, accelerate wound closure, control infection, and enable functional tissue regeneration. This is not a contract award announcement but a sources-sought notice designed to inform future acquisition strategies by assessing the current landscape of medical countermeasure innovations. Respondents are encouraged to submit documentation demonstrating the readiness, performance, and scalability of their technologies to meet operational needs in high-volume, high-acuity environments. The opportunity is open for responses until August 28, 2026, at 8:00 PM Eastern Time, with all submissions directed to the point of contact, Yifan Yang, at yifan.yang@hhs.gov. The procurement falls under NAICS code 339113, which pertains to medical appliance and equipment manufacturing, and is administered by the Administration for Strategic Preparedness and Response within the U.S. Department of Health and Human Services. There is no small business set-aside, and the office is based in Washington, D.C. The place of performance is also located in the District of Columbia, indicating that evaluation and potential oversight will be centralized at the federal level. Interested parties can access further details through the provided SAM.gov link.
Surgical Appliance and Supplies Manufacturing

POSTED

1 day ago

DEADLINE

in about 1 month
View Details